rs143486492
Variant summary
The NM_000492.4(CFTR):c.890G>A (p.Arg297Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene CFTR is a tumor suppressor gene (CancerMine: 18 TSG, 1 driver citations). The gene CFTR is a cancer driver gene (CancerMine: 18 TSG, 1 driver citations). The variant allele was found at a cumulative frequency of 0.000885 (AC=1,427) in the gnomAD database across 1,613,130 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.00107. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (no review stars). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R297= (synonymous): Likely_benign (ClinVar VariationId 1765115, 1 star); p.R297= (synonymous): Likely_benign (ClinVar VariationId 4843833, 1 star); p.R297W: Uncertain_significance (ClinVar VariationId 54080, 2 stars) The variant has been observed in cBioPortal in 2 samples across 2 studies and 2 cancer types; somatic enrichment level: SUPPORTING_LOW (Observed in a small number of cBioPortal cases.). This exact variant is curated in the UniProt human variants database as Uncertain Significance.
Frequency
Consequence
NM_000492.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital bilateral aplasia of vas deferens from CFTR mutationInheritance: AR Classification: DEFINITIVE Submitted by: Natera
- cystic fibrosisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Myriad Women's Health, ClinGen, Natera, Orphanet
- congenital bilateral absence of vas deferensInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary chronic pancreatitisInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 1 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000492.4. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CFTR | TSL:1MANE Select | c.890G>A p.Arg297Gln | missense | Exon 8 of 27 | Prot: ENSP00000003084.6 UniProt: | |
CFTR | c.890G>A p.Arg297Gln | missense | Exon 8 of 27 | Prot: ENSP00000514471.1 UniProt: | ||
CFTR | c.890G>A p.Arg297Gln | missense | Exon 8 of 26 | Prot: ENSP00000559265.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.000677 | AC:103 | Hom:1 | AN:152058 | Cov:32 |
GnomAD2 exomes | AF: 0.000567 | AC:142 | AN:250572 | ||
GnomAD4 exome | AF: 0.000907 | AC:1325 | Hom:0 | AN:1460952 | Cov:30 |
GnomAD4 genome | AF: 0.000670 | AC:102 | Hom:0 | AN:152178 | Cov:32 |
TOPMed (Bravo) | AF: 0.000552 | AC:146 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.000907 | AC:213 | Hom:0 | AN:234820 | |
Local & regional cohorts 8 sources | |||||
ABraOM SABE-WGS-1171 | AF: 0.000427 | AC:1 | Hom:0 | AN:2342 | |
ChinaMAP Phase 1 | AF: 0.000443 | ||||
ESP6500 (Exome Variant Server) | AF: 0.00131 | AC:17 | AN:13006 | ||
GenomeAsia100K | AF: 0.00289 | AC:10 | AN:3478 | ||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.0000240 | AC:3 | Hom:0 | AN:122692 | |
Turkish Variome | AF: 0.00104 | AC:7 | Hom:0 | AN:6718 | |
UK10K | AF: 0.000132 | AC:1 | AN:7562 | ||
WBBC (Westlake BioBank for Chinese) pilot | AF: 0.000223 | AC:2 | Hom:0 | AN:8960 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.000451 * | 5 | 11078 | 0.000455 * | 8 | 17568 |
BipEx | 0.000915 | 26 | 28418 | 0.000728 | 21 | 28838 |
Epi25 | 0.000644 | 27 | 41956 | 0.000957 | 64 | 66884 |
SCHEMA | 0.000525 | 64 | 121906 | 0.000582 | 111 | 190710 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Uncertain | 17 | |
AlphaMissense | Benign | 0.068 | |
BayesDel_addAF | Uncertain | 0.081 | D |
BayesDel_noAF | Pathogenic | 0.34 | |
CADD | Benign | 22 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Uncertain | 0.69 | D |
Eigen | Uncertain | 0.29 | |
Eigen_PC | Uncertain | 0.42 | |
FATHMM_MKL | Pathogenic | 0.98 | D |
FuncVEP CTI | Benign | 0.052 | |
GPN-Star LLR | N/A | -5.5 | |
GPN-Star score | N/A | 5.3 | |
LIST_S2 | Uncertain | 0.89 | D |
M_CAP | Pathogenic | 0.53 | D |
MetaRNN | Benign | 0.20 | T |
MetaSVM | Uncertain | 0.35 | D |
Mutation Taster | N/A | 8/92 | disease causing |
MutationAssessor | Uncertain | 2.1 | M |
PhyloP100 | Uncertain | 6.4 | |
popEVE | Benign | -3.1 | |
PrimateAI | Benign | 0.41 | T |
PROVEAN | Benign | -2.2 | N |
REVEL | Pathogenic | 0.72 | |
Sift | Uncertain | 0.025 | D |
Sift4G | Uncertain | 0.038 | D |
Varity_R | N/A | 0.72 | |
VESM-3B | Benign | -6.5 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.050 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.